Open Insider Trading Activity for Arrowhead Pharmaceuticals, Inc. Chief Executive Officer Anzalone Christopher Richard
31-day price and insider activity (up to 2 years)
Daily candles with triangles for the buy and sale transactions shown below. Scroll left or zoom out to load earlier candles (up to 2 years).
▲ Insider buy
▼ Insider sale
Loading daily price history…
Charting by TradingView Lightweight Charts
| Ticker | Filing Date | Transaction Date | Company | Insider | Title | Transaction | Trade Count | Shares | Avg. Price | Total Value | Position Size Change | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10b5-1: Scheduled Form 4 Transaction ARWR | 2026-01-05 | 2026-01-02 | Arrowhead Pharmaceuticals, Inc. | Anzalone Christopher Richard | Chief Executive Officer | Sell | 2 | 13,187 | $66.10 | $871,702.77 | 0.17% | View Filing |
| 10b5-1: Scheduled Form 4 Transaction ARWR | 2025-12-30 | 2025-12-29 | Arrowhead Pharmaceuticals, Inc. | Anzalone Christopher Richard | Chief Executive Officer | Sell | 2 | 51,726 | $69.13 | $3,575,574.78 | 0.67% | View Filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting ARWR | 2025-12-19 | 2025-12-17 | Arrowhead Pharmaceuticals, Inc. | Anzalone Christopher Richard | Chief Executive Officer | Sell | 4 | 85,000 | $64.04 | $5,443,462.11 | 0.55% | View Filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting ARWR | 2025-04-11 | 2025-04-11 | Arrowhead Pharmaceuticals, Inc. | Anzalone Christopher Richard | Chief Executive Officer | Sell | 5 | 141,122 | $10.87 | $1,533,336.57 | 0.70% | View Filing |